inactivated-adjuvanted SARS-CoV-2 virus vaccine
Showing 51 - 75 of >10,000
SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)
Active, not recruiting
- SARS-CoV-2
- RBMRNA-176
- Placebo
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)
Completed
- SARS-CoV-2 Virus
- SARS-CoV-2 RNA detection
-
Bangkok, Thailand2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023
COVID-19, Vaccines Trial in Santiago (CoronaVac®, Omicron Vaccine, Trivalent Vaccine)
Recruiting
- COVID-19
- Vaccines
- CoronaVac®
- +2 more
-
Santiago, Metropolitana, Chile
- +2 more
Jan 12, 2023
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
COVID-19 Virus Infection Trial in Ciudad Autónoma de Buenos Aires (Inactivated SARS-CoV-2 vaccine (Vero cell), Placebo/Aluminum
Completed
- COVID-19 Virus Infection
- Inactivated SARS-CoV-2 vaccine (Vero cell)
- Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- +3 more
Jan 11, 2022
COVID-19 Trial in Xi'an (Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2, Inactivated SARS-CoV-2 Vaccine
Active, not recruiting
- COVID-19
- Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
- +6 more
-
Xi'an, Shanxi, ChinaYaliang county Center for Disease Control and Prevention
Dec 13, 2021
COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))
Not yet recruiting
- COVID-19
- XBB.1.5 Vaccine (Booster)
- XBB.1.5 Vaccine (single dose)
-
Mobile, Alabama
- +29 more
Aug 4, 2023
Sars-CoV-2 Infection Trial in Negrar (Nasal and mouth swab)
Active, not recruiting
- Sars-CoV-2 Infection
- Nasal and mouth swab
-
Negrar, Verona, ItalyIRCCS Sacro Cuore Don Calabria hospital
Mar 14, 2023
SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 variant mRNA vaccine low dose
- SARS-CoV-2 variant mRNA vaccine high dose
- (no location specified)
Oct 30, 2022
SARS-CoV2 Infection Trial in Mile (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))
Recruiting
- SARS-CoV2 Infection
- SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
-
Mile, Yunnan, ChinaMile City Centers for Disease Control and Prevention
Feb 14, 2022
SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)
Not yet recruiting
- SARS CoV 2 Infection
- Influenza, Human
- BIMERVAX
- SIIV
-
Santiago De Compostela, A Coruña, Spain
- +7 more
Aug 8, 2023
SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- Recombinant protein vaccine and adenovirus vector vaccine
- (no location specified)
Feb 12, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- QTP104 1ug
- +2 more
-
Seoul, Korea, Republic of
- +1 more
May 24, 2023
SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)
Active, not recruiting
- SARS-CoV-2 Infection
- VLA2001
-
Groningen, Netherlands
- +3 more
Jan 17, 2023
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
COVID-19 Trial in Langhorne (BBV152)
Available
- COVID-19
- BBV152
-
Langhorne, PennsylvaniaWoods
Sep 14, 2022
SARS-CoV-2 Infection Trial in Anning (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))
Recruiting
- SARS-CoV-2 Infection
- SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
-
Anning, Yunnan, ChinaAnning First People's Hospital
Feb 14, 2022
SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
- +2 more
- (no location specified)
Dec 1, 2022
COVID-19 Trial (SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated)
Not yet recruiting
- COVID-19
- SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated
- (no location specified)
Dec 23, 2021
SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
- +2 more
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Jan 3, 2023
COVID-19 Trial in Vitória (Inactivated Coronavac/Butantan vaccine, BNT162b2 (Pfizer))
Recruiting
- COVID-19
- Inactivated Coronavac/Butantan vaccine
- BNT162b2 (Pfizer)
-
Vitória, Espírito Santo, BrazilValéria Valim
Feb 1, 2022
COVID-19 Trial ("Sputnik Lite" vaccine for the prevention of COVID-19 with altered antigenic composition)
Not yet recruiting
- COVID-19
- "Sputnik Lite" vaccine for the prevention of COVID-19 with altered antigenic composition
- (no location specified)
Sep 26, 2023
COVID-19 Trial in Barranquilla, Cali (Candidate vaccine, SCB-2019)
Not yet recruiting
- COVID-19
- Candidate vaccine, SCB-2019
-
Barranquilla, Colombia
- +1 more
Aug 23, 2022
Immunogenicity ofThird-dose Booster After Two Doses
Recruiting
- COVID-19
- Vaccine Reaction
- an inactivated SARS-CoV-2 vaccine named BBIBP-CorV
-
Shanghai, ChinaInfectious department of Huashan Hospital, Fudan University
Aug 7, 2022